ANZCA President Professor David Story noted near misses, last-minute cancellations, or worse, the risks of an immediate crisis and a long ICU stay, even mortality
However, it's important to note that the study was sponsored by a sublingual GSH company ( 6 )
Atkinson and Stephen Ezell for helpful feedback on this report
The prevalence of clinically significant PBH varies considerably, with estimates ranging from 0.2% to 34% depending on diagnostic criteria (symptomatic reporting versus continuous glucose monitoring) and surgical procedure (more common after RYGB than sleeve gastrectomy)
Examples include Wegovy (injectable and pill), Ozempic, Zepbound, and Mounjaro
Cost or access issues make tirzepatide impractical, as semaglutide has broader insurance coverage and more compounding options